3006
COM:BIOKANGTAI
深圳康泰生物制品股份有限公司
- Stock
Last Close
19.05
22/11 07:04
Market Cap
16.99B
Beta: -
Volume Today
15.14M
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '13 | Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
average inventory | 138.25M - | 144.74M 4.69% | 129.89M 10.26% | 125.97M 3.01% | 160.97M 27.78% | 188.46M 17.08% | 212.42M 12.71% | 332.65M 56.60% | 747.37M 124.67% | 893.00M 19.49% | 750.33M 15.98% | |
average payables | 31.01M - | 40.44M 30.40% | 39.11M 3.29% | 37.08M 5.19% | 48.22M 30.02% | 79.49M 64.86% | 107.49M 35.23% | 141.97M 32.07% | 437.78M 208.37% | 571.16M 30.47% | 612.65M 7.26% | |
average receivables | 124.09M - | 154.70M 24.67% | 168.28M 8.78% | 237.10M 40.90% | 425.06M 79.28% | 729.25M 71.56% | 990.01M 35.76% | 1.42B 43.25% | 1.88B 32.46% | 2.20B 17.27% | 2.62B 18.79% | |
book value per share | 0.41 - | 0.70 71.09% | 0.73 3.86% | 0.82 11.97% | 1.09 33.33% | 1.84 68.66% | 2.73 48.15% | 7.07 159.44% | 13.42 89.75% | 8.12 39.47% | 8.53 4.99% | |
capex per share | -0.14 - | -0.11 24.97% | -0.13 24.45% | -0.19 42.58% | -0.19 1.10% | -0.35 78.63% | -0.38 10.90% | -1.16 203.76% | -3.72 219.96% | -1.18 68.15% | -0.64 45.79% | |
capex to depreciation | -2.68 - | -1.83 31.85% | -2.36 29.18% | -3.75 58.83% | -3.28 12.65% | -5.94 81.13% | -4.66 21.50% | -13.20 183.30% | -6.28 52.44% | -6.52 3.89% | -2.98 54.23% | |
capex to operating cash flow | -4.92 - | -0.80 83.80% | -0.43 46.43% | -2.19 413.06% | -1.23 43.80% | -1.02 17.06% | -0.76 25.15% | -2.79 264.77% | -1.54 44.87% | -2.40 56.18% | -0.66 72.64% | |
capex to revenue | -0.52 - | -0.29 43.20% | -0.26 11.01% | -0.31 18.63% | -0.16 47.48% | -0.17 4.34% | -0.20 16.75% | -0.54 172.67% | -0.70 28.23% | -0.42 40.34% | -0.21 49.85% | |
cash per share | 0.08 - | 0.27 216.30% | 0.17 36.80% | 0.12 26.89% | 0.16 31.82% | 0.64 291.53% | 0.50 21.51% | 2.88 475.69% | 5.20 80.52% | 1.32 74.63% | 1.57 19.24% | |
days of inventory on hand | 658.37 - | 562.69 14.53% | 244.51 56.55% | 435.36 78.05% | 484.13 11.20% | 398.92 17.60% | 510.14 27.88% | 704.09 38.02% | 391.56 44.39% | 531.35 35.70% | 452.98 14.75% | |
days payables outstanding | 191.83 - | 150.87 21.35% | 84.47 44.01% | 110.69 31.03% | 162.13 46.47% | 200.22 23.50% | 259.96 29.83% | 269.93 3.84% | 262.05 2.92% | 316.95 20.95% | 463.72 46.31% | |
days sales outstanding | 212.74 - | 196.58 7.59% | 139.61 28.98% | 199.07 42.59% | 172.60 13.30% | 164.57 4.65% | 201.09 22.19% | 285.03 41.74% | 199.01 30.18% | 279.15 40.27% | 298.11 6.79% | |
debt to assets | 0.45 - | 0.34 22.69% | 0.20 42.57% | 0.22 10.18% | 0.13 39.17% | 0.14 4.30% | 0.06 53.20% | 0.01 85.31% | 0.19 1,934.09% | 0.17 14.19% | 0.17 1.66% | |
debt to equity | 1.33 - | 0.79 40.25% | 0.41 48.50% | 0.48 16.43% | 0.27 42.35% | 0.25 8.02% | 0.09 63.11% | 0.01 86.86% | 0.30 2,344.84% | 0.25 14.70% | 0.27 4.75% | |
dividend yield | 0.02 - | 0.02 7.28% | 0.01 26.36% | 0.01 28.58% | 0.00 77.82% | 0.00 48.92% | 0.00 11.15% | 0.00 44.00% | 0.01 190.08% | 0.02 235.80% | 0.01 62.90% | |
earnings yield | 0.00 - | 0.02 2,150.00% | 0.03 88.89% | 0.04 35.29% | 0.01 77.19% | 0.02 103.15% | 0.01 47.25% | 0.01 43.14% | 0.03 407.53% | -0.00 112.50% | 0.03 845.18% | |
enterprise value | 2.43B - | 2.09B 14.14% | 2.08B 0.11% | 2.23B 7.30% | 21.94B 881.46% | 21.61B 1.51% | 54.19B 150.81% | 112.39B 107.42% | 40.67B 63.81% | 36.14B 11.14% | 31.72B 12.23% | |
enterprise value over ebitda | 25.37 - | 18.63 26.57% | 15.30 17.87% | 13.19 13.83% | 68.32 418.14% | 36.60 46.43% | 70.24 91.91% | 129.05 83.74% | 19.11 85.20% | 38.12 99.55% | 31.23 18.07% | |
ev to operating cash flow | 92.05 - | 18.61 79.78% | 7.50 59.72% | 28.54 280.64% | 142.45 399.22% | 64.21 54.93% | 107.15 66.88% | 255.53 138.47% | 24.62 90.37% | 66.23 169.05% | 29.00 56.21% | |
ev to sales | 9.69 - | 6.87 29.10% | 4.60 33.07% | 4.05 11.99% | 18.89 366.52% | 10.71 43.29% | 27.88 160.30% | 49.71 78.26% | 11.14 77.60% | 11.45 2.78% | 9.19 19.72% | |
free cash flow per share | -0.11 - | 0.03 123.93% | 0.18 556.82% | -0.10 157.79% | -0.04 65.04% | -0.01 80.04% | 0.12 1,725.65% | -0.75 732.63% | -1.30 74.39% | -0.69 46.83% | 0.34 148.52% | |
free cash flow yield | -0.05 - | 0.01 123.93% | 0.08 556.82% | -0.05 157.79% | -0.00 96.50% | -0.00 79.72% | 0.00 759.68% | -0.01 417.80% | -0.02 207.99% | -0.02 2.43% | 0.01 156.35% | |
graham net net | -0.53 - | -0.41 22.60% | -0.40 2.91% | -0.51 28.51% | -0.49 4.70% | -0.09 81.65% | 0.22 348.69% | 2.33 949.34% | 0.86 62.95% | -1.06 222.25% | -0.85 19.12% | |
graham number | 0.12 - | 0.77 520.45% | 1.08 40.06% | 1.33 23.08% | 2.32 74.31% | 4.26 83.66% | 5.91 38.78% | 10.12 71.36% | 23.64 133.52% | 4.68 80.19% | 12.16 159.55% | |
income quality | 17.47 - | 3.60 79.41% | 4.42 23.00% | 0.91 79.46% | 0.72 21.06% | 0.77 7.68% | 0.88 13.98% | 0.65 26.43% | 1.31 101.95% | -4.11 414.42% | 1.27 130.88% | |
intangibles to total assets | 0.15 - | 0.13 13.40% | 0.13 4.46% | 0.12 10.43% | 0.10 18.30% | 0.06 37.31% | 0.09 50.96% | 0.04 58.52% | 0.05 35.77% | 0.03 33.77% | 0.03 3.02% | |
interest coverage | -2.18 - | 1.77 181.40% | 7.64 331.50% | 40.97 436.01% | 111.43 171.99% | 20.11 81.95% | 73.65 266.26% | 331.69 350.35% | 26.64 91.97% | 6.86 74.27% | 5.95 13.18% | |
interest debt per share | 0.56 - | 0.58 3.45% | 0.31 47.01% | 0.39 26.81% | 0.30 23.03% | 0.49 61.98% | 0.26 46.22% | 0.09 66.20% | 4.09 4,513.22% | 2.17 46.97% | 2.39 10.34% | |
inventory turnover | 0.55 - | 0.65 17.00% | 1.49 130.13% | 0.84 43.84% | 0.75 10.07% | 0.91 21.36% | 0.72 21.80% | 0.52 27.55% | 0.93 79.82% | 0.69 26.31% | 0.81 17.30% | |
invested capital | 1.33 - | 0.79 40.25% | 0.41 48.50% | 0.48 16.43% | 0.27 42.35% | 0.25 8.02% | 0.09 63.11% | 0.01 86.86% | 0.30 2,344.84% | 0.25 14.70% | 0.27 4.75% | |
market cap | 2.01B - | 1.84B 8.31% | 1.97B 6.73% | 2.00B 1.43% | 21.80B 991.93% | 21.78B 0.11% | 54.44B 149.96% | 113.18B 107.92% | 41.48B 63.35% | 34.87B 15.94% | 30.37B 12.90% | |
net current asset value | -354.94M - | -209.37M 41.01% | -225.54M 7.72% | -286.09M 26.85% | -150.02M 47.56% | 236.58M 257.70% | 630.02M 166.31% | 3.22B 411.65% | 2.36B 26.84% | 373.84M 84.15% | 181.03M 51.57% | |
net debt to ebitda | 4.36 - | 2.15 50.59% | 0.84 60.91% | 1.41 67.09% | 0.42 70.40% | -0.29 170.35% | -0.32 10.33% | -0.91 181.37% | -0.38 58.06% | 1.34 451.97% | 1.33 0.84% | |
net income per share | 0.00 - | 0.04 2,150.00% | 0.07 88.89% | 0.10 35.29% | 0.22 127.87% | 0.44 100.00% | 0.57 30.00% | 0.64 13.19% | 1.85 187.38% | -0.12 106.49% | 0.77 741.67% | |
operating cash flow per share | 0.03 - | 0.14 363.22% | 0.31 132.33% | 0.09 72.21% | 0.16 79.89% | 0.34 115.36% | 0.50 48.17% | 0.42 16.73% | 2.42 480.35% | 0.49 79.61% | 0.98 98.16% | |
payables turnover | 1.90 - | 2.42 27.15% | 4.32 78.60% | 3.30 23.68% | 2.25 31.73% | 1.82 19.03% | 1.40 22.98% | 1.35 3.69% | 1.39 3.01% | 1.15 17.32% | 0.79 31.65% | |
receivables turnover | 1.72 - | 1.86 8.22% | 2.61 40.81% | 1.83 29.87% | 2.11 15.34% | 2.22 4.88% | 1.82 18.16% | 1.28 29.45% | 1.83 43.22% | 1.31 28.71% | 1.22 6.36% | |
research and ddevelopement to revenue | 0.15 - | 0.15 3.60% | 0.11 29.31% | 0.07 32.81% | 0.07 1.88% | 0.09 20.82% | 0.10 15.71% | 0.12 15.77% | 0.10 17.87% | 0.25 161.81% | 0.13 47.83% | |
return on tangible assets | 0.00 - | 0.03 1,562.94% | 0.05 104.17% | 0.06 12.53% | 0.11 75.97% | 0.14 29.24% | 0.16 15.14% | 0.07 53.99% | 0.09 27.83% | -0.01 110.58% | 0.06 692.50% | |
revenue per share | 0.28 - | 0.37 32.08% | 0.51 39.84% | 0.61 20.19% | 1.18 92.50% | 2.03 71.19% | 1.92 5.01% | 2.14 11.40% | 5.35 149.53% | 2.86 46.61% | 3.09 8.09% | |
roe | 0.00 - | 0.05 1,215.09% | 0.10 81.87% | 0.12 20.83% | 0.20 70.91% | 0.24 18.58% | 0.21 12.25% | 0.09 56.37% | 0.14 51.45% | -0.01 110.72% | 0.09 711.18% | |
roic | 0.76 - | 0.03 95.89% | 0.07 115.78% | 0.07 2.63% | 0.16 132.64% | 0.19 16.68% | 0.19 1.28% | 0.09 52.31% | 0.11 18.65% | 0.03 75.72% | 0.06 125.85% | |
sales general and administrative to revenue | 0.11 - | 0.06 46.80% | 0.04 36.48% | 0.04 15.09% | 0.03 30.44% | 0.02 33.47% | 0.02 20.82% | 0.02 3.27% | 0.02 14.48% | 0.02 2.76% | ||
shareholders equity per share | 0.41 - | 0.70 71.09% | 0.73 3.86% | 0.82 11.97% | 1.09 33.33% | 1.84 68.66% | 2.73 48.15% | 7.07 159.44% | 13.42 89.75% | 8.12 39.47% | 8.53 4.99% | |
stock based compensation to revenue | ||||||||||||
tangible asset value | 208.93M - | 412.41M 97.40% | 469.17M 13.76% | 543.70M 15.89% | 855.19M 57.29% | 1.63B 90.44% | 2.39B 46.69% | 7.10B 197.03% | 8.43B 18.80% | 8.51B 0.95% | 9.37B 10.06% | |
tangible book value per share | 0.23 - | 0.50 115.29% | 0.53 6.59% | 0.61 14.25% | 0.87 43.92% | 1.64 87.69% | 2.37 44.62% | 6.73 184.38% | 12.34 83.55% | 7.70 37.66% | 8.82 14.67% | |
working capital | 114.91M - | 203.71M 77.27% | 146.24M 28.21% | 170.47M 16.57% | 213.20M 25.07% | 766.21M 259.39% | 958.02M 25.03% | 3.59B 274.59% | 4.72B 31.60% | 2.84B 39.97% | 2.64B 6.72% |
All numbers in (except ratios and percentages)